Related News

March 27, 2020

Below are the three companies in the Pharmaceuticals industry with the highest betas. Higher-beta stocks mean greater volatility and are therefore generally considered to be riskier but also may provide the potential for higher returns.

...

March 13, 2020

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on October 18th, 2018 at $23.44. In approximately 17 months, Endocyte Inc has returned 2.37% as of today's recent price of $23.99.

In the past...

March 13, 2020

Below are the three companies in the Pharmaceuticals industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Aerie Pharmaceut ranks lowest with a sales...

March 5, 2020

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on October 18th, 2018 at $23.44. In approximately 17 months, Endocyte Inc has returned 2.37% as of today's recent price of $23.99.

Over the...

February 28, 2020

Below are the three companies in the Pharmaceuticals industry with the highest betas. Higher-beta stocks mean greater volatility and are therefore generally considered to be riskier but also may provide the potential for higher returns.

...

February 27, 2020

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on October 18th, 2018 at $23.44. In approximately 17 months, Endocyte Inc has returned 2.37% as of today's recent price of $23.99.

In the past...

February 19, 2020

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on October 18th, 2018 at $23.44. In approximately 16 months, Endocyte Inc has returned 2.37% as of today's recent price of $23.99.

Endocyte Inc...

February 15, 2020

Below are the three companies in the Pharmaceuticals industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Aerie Pharmaceut ranks lowest with a sales...

February 10, 2020

Below are the three companies in the Pharmaceuticals industry with the lowest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Endocyte Inc ranks lowest with a an RPE...

February 8, 2020

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on October 18th, 2018 at $23.44. In approximately 16 months, Endocyte Inc has returned 2.37% as of today's recent price of $23.99.

Over the...